Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices. (Q40449743)
Jump to navigation
Jump to search
scientific article published on May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices. |
scientific article published on May 2007 |
Statements
1 reference
Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices. (English)
1 reference
Vicki A Morrison
1 reference
Mitchell Wong
1 reference
Dawn Hershman
1 reference
Luis T Campos
1 reference
Beiying Ding
1 reference
Jennifer Malin
1 reference
1 May 2007
1 reference
1 reference
13
1 reference
4
1 reference
337-348
1 reference
Identifiers
1 reference